Paul A Gerlach, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2985 Cortez Ave, Idaho Falls, ID 83404 Phone: 208-523-3373 Fax: 208-523-8746 |
Dr. Patrick D Gorman, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2985 Cortez Ave, Idaho Falls, ID 83404 Phone: 208-523-3373 Fax: 208-523-8746 |
Mr. Ricky Dwayne Latham, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2001 Valenica Drive, Suite 201, Idaho Falls, ID 83404 Phone: 208-524-9400 Fax: 208-524-9401 |
John E Lassetter, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2001 S Woodruff Ave Ste 3, Idaho Falls, ID 83404 Phone: 208-523-3050 Fax: 208-523-4985 |
Mr. John D Chambers Jr., M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2985 Cortez Ave, Idaho Falls, ID 83404 Phone: 208-523-3373 Fax: 208-523-8746 |
Kipp B Webb, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2985 Cortez Ave, Idaho Falls, ID 83404 Phone: 208-523-3373 Fax: 208-523-8746 |
Mr. Douglas U. Blank, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2985 Cortez Ave, Idaho Falls, ID 83404 Phone: 208-523-3373 Fax: 208-523-8746 |
News Archive
The American Urological Association (AUA) today announced that submissions are now being accepted for the 6th Annual Excellence in Urology Health Reporting Awards, designed to recognize outstanding news coverage of urologic disease topics. Presentation of the awards will take place during the AUA Annual Scientific Meeting in Atlanta, GA, in May.
Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.
One of the largest and longest-running efforts to evaluate the potential benefits of the Mediterranean-style diet in lowering risk of stroke found that the diet may be especially protective in women over 40 regardless of menopausal status or hormone replacement therapy, according to new research in the American Heart Association's journal Stroke.
Scientists are reporting a test which can predict which patients are most at risk from aggressive prostate cancer, and whether they suffer an increased chance of treatment failure.
› Verified 5 days ago